| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2006 | WO2006050161A2 Therapeutic furopyrimidines and thienopyrimidines |
| 05/11/2006 | WO2006050148A2 Propargyl trifluoromethoxy aminobenzimidazole derivatives |
| 05/11/2006 | WO2006050126A1 Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of obesity |
| 05/11/2006 | WO2006050123A1 Spontaneously dispersible pharmaceutical compositions |
| 05/11/2006 | WO2006050101A1 Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 05/11/2006 | WO2006050097A1 Substituted phenylalkanoic acids |
| 05/11/2006 | WO2006050076A1 Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| 05/11/2006 | WO2006050075A2 Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents |
| 05/11/2006 | WO2006050057A2 Methods and compositions using pde4 modulators for treatment and management of central nervous system injury |
| 05/11/2006 | WO2006050053A2 Compounds and methods of use thereof |
| 05/11/2006 | WO2006050048A1 Cyclohexyldiamines as selective alpha 1a/1d adrenoreceptor antagonists for the treatment of benign prostatic hypertrophy and lower urinary tract symptoms |
| 05/11/2006 | WO2006050045A2 Inhibitors of jun n-terminal kinases for treating glaucomatous retinopathy and ocular diseases |
| 05/11/2006 | WO2006050037A1 Adjunctive therapy for depression |
| 05/11/2006 | WO2006050035A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006050034A1 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents |
| 05/11/2006 | WO2006050026A2 Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
| 05/11/2006 | WO2006050006A2 ((1h-indazol-3-yl)methyl) phenols and (hydroxyphenyl)(1h-indazol-3-yl) methanones as ligands of the estrogen receptor |
| 05/11/2006 | WO2006050002A2 Compositions for controlled delivery of pharmaceutically active compounds |
| 05/11/2006 | WO2006049986A1 Polymorphic forms of tadalafil |
| 05/11/2006 | WO2006049984A2 Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
| 05/11/2006 | WO2006049978A1 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption |
| 05/11/2006 | WO2006049968A1 Pyrimidine and quinoline potentiators of metabotropic glutamate receptors |
| 05/11/2006 | WO2006049957A2 Method for treating glioma |
| 05/11/2006 | WO2006049952A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/11/2006 | WO2006049941A2 Diaryl ureas as cb1 antagonists |
| 05/11/2006 | WO2006049933A2 Compositions and methods for the treatment of obesity and sexual dysfunction |
| 05/11/2006 | WO2006049891A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 05/11/2006 | WO2006049890A1 Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 05/11/2006 | WO2006049889A1 Indole derivatives useful as progesterone receptor modulators |
| 05/11/2006 | WO2006049880A1 Tetrahydro pyridinyl pyrazole cannabinoid modulators |
| 05/11/2006 | WO2006049813A2 Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| 05/11/2006 | WO2006049812A2 Process for treating a biological organism |
| 05/11/2006 | WO2006049764A2 Methods of making 2,6-diaryl piperidine derivatives |
| 05/11/2006 | WO2006049739A1 Method for treating bacterial infections in horses or pigs with tilmicosin |
| 05/11/2006 | WO2006049734A2 Quetiapine analogs and methods of use thereof |
| 05/11/2006 | WO2006049657A2 Insulin secretion by anthocyanins and anthocyanidins |
| 05/11/2006 | WO2006049565A1 New modified release tablet formulations for proton pump inhibitors |
| 05/11/2006 | WO2006049564A1 New modified release pellet formulations for proton pump inhibitors |
| 05/11/2006 | WO2006049463A1 Hemostatic agent internally applied through endoscope and application method thereof |
| 05/11/2006 | WO2006049454A1 Therapeutic use of cpg oligodeoxynucleotide for skin disease |
| 05/11/2006 | WO2006049447A1 Pharmaceutical formulation for increasing solubility of 10-hydroxycamptothecin compounds in non-aqueous polar solvents |
| 05/11/2006 | WO2006049442A1 Pharmaceutical compositions for transdermal delivery |
| 05/11/2006 | WO2006049433A1 Solid dispersion composition of pranlukast with improved bioavailibility and the method of preparing the solid dispersion |
| 05/11/2006 | WO2006049416A1 Use of metabolites of arachidonic acid or the derivative thereof |
| 05/11/2006 | WO2006049404A1 Sphingosine kinase activator and skin disease treating agent comprising the same |
| 05/11/2006 | WO2006049339A1 Novel fused imidazole derivative |
| 05/11/2006 | WO2006049312A1 Remedy for neuropathic pain |
| 05/11/2006 | WO2006049304A1 Aryloxy-substituted benzimidazole derivatives |
| 05/11/2006 | WO2006049286A1 Preventive/remedy for allergic diseases |
| 05/11/2006 | WO2006049258A1 Polymeric polyphenol extracted from fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage |
| 05/11/2006 | WO2006049250A1 Aqueous eye drops with accelerated intraocular migration |
| 05/11/2006 | WO2006049248A1 Analgesic |
| 05/11/2006 | WO2006049234A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same |
| 05/11/2006 | WO2006049232A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006049157A1 Multimeric oleamide derivative having connexin-26 inhibiting potency and use thereof in cancer therapy, etc. |
| 05/11/2006 | WO2006049148A1 1β-METHYLCARBAPENEM DERIVATIVE |
| 05/11/2006 | WO2006049078A1 Drug for external use for treating skin disease |
| 05/11/2006 | WO2006048911A2 Pharmaceutical or nutraceutical compositions containing chromium or iron complexes of alpha-lipoic acid |
| 05/11/2006 | WO2006048894A1 Novel crystalline forms of atorvastatin calcium and processes for preparing them. |
| 05/11/2006 | WO2006048892A2 Method for selectively occluding blood supplies to neoplasia |
| 05/11/2006 | WO2006048891A1 Method of stabilizing and potentiating the action of anti-angiogenic substances |
| 05/11/2006 | WO2006048884A1 Therapeutic treatment of accelerated bone resorption |
| 05/11/2006 | WO2006048773A1 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation |
| 05/11/2006 | WO2006048771A1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 05/11/2006 | WO2006048768A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 05/11/2006 | WO2006048751A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | WO2006048750A2 Novel compounds of substituted and unsubstituted adamantyl amides |
| 05/11/2006 | WO2006048747A1 Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound |
| 05/11/2006 | WO2006048744A1 Methods of preparing indazole compounds |
| 05/11/2006 | WO2006048727A1 Piperazinylphenalkyl lactam/amine ligands for the 5ht1b receptor |
| 05/11/2006 | WO2006048639A1 Hydrogel delivery vehicle |
| 05/11/2006 | WO2006048633A2 Combination comprising zd6474 and an antiandrogen |
| 05/11/2006 | WO2006048628A1 Bacterial compositions for prevention or treatment of atherosclerotic disorders |
| 05/11/2006 | WO2006048601A1 Thermally responsive polymers |
| 05/11/2006 | WO2006048501A1 A transmucosal veterinary composition comprising detomidine |
| 05/11/2006 | WO2006048457A1 Probiotica and polyphenol |
| 05/11/2006 | WO2006048430A1 SALTS OF N-ACYL-L-ASPARTATE-β-MONOESTER AND/OR OF N-ACYL-L-GLUTAMATE-Ϝ-MONOESTER, METHOD FOR THE PREPARATION THEREOF AND THEIR USE IN THERAPEUTIC OR COSMETIC COMPOSITIONS |
| 05/11/2006 | WO2006048427A1 Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 05/11/2006 | WO2006048336A2 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 05/11/2006 | WO2006048331A1 11β-HSD1 INHIBITORS |
| 05/11/2006 | WO2006048330A1 11βετα-hsd1 inhibitors |
| 05/11/2006 | WO2006048315A1 Use of an amino-tetraline derivative as anti-arrhythmic agent |
| 05/11/2006 | WO2006048308A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/11/2006 | WO2006048294A1 Combinations of nicotinic acetylcholine alpha 7 receptor agonists |
| 05/11/2006 | WO2006048261A2 Oral solid dosage forms containing a low dose of estradiol |
| 05/11/2006 | WO2006048251A1 Anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 05/11/2006 | WO2006048237A1 Novel polymorph forms of candesartan cilexetil |
| 05/11/2006 | WO2006048225A1 Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists |
| 05/11/2006 | WO2006048219A1 Use of s-enantiomers of alpha-substituted aryl acetic acids for the prevention of alzheimer’s disease |
| 05/11/2006 | WO2006048209A1 Novel bradykinin b1 antagonists, method for producing the same and the use thereof as drugs |
| 05/11/2006 | WO2006048208A1 Bilayer tablet comprising telmisartan and amlodipine |
| 05/11/2006 | WO2006048194A1 Stable aqueous formulation of a platin derivative |
| 05/11/2006 | WO2006048146A1 Quinoline as allosteric enhancers of the gaba-b receptors |
| 05/11/2006 | WO2006048017A1 Lipid-based drug delivery systems containing unnatural phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 05/11/2006 | WO2006047931A1 The use of dipyridamole in manufacturing the anti-malignant tumor medicines |
| 05/11/2006 | WO2006047891A1 Polycyclic aromatics and derivatives thereof and processes for their preparation |
| 05/11/2006 | WO2006047859A1 Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
| 05/11/2006 | WO2006047800A1 Biocide in particular an agent with fungicidal activity |
| 05/11/2006 | WO2006035960A3 Process for production of 2-chloro-4-nitroimidazole |